The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Supreme Court dismisses plea mandating doctors to specify drug side effects, citing impracticality and existing regulations.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

The Supreme Court on Thursday dismissed a plea seeking a direction to mandate medical professionals to specify to patients ...

Yes, it’s technically possible to overdose on Ozempic—but it’s unlikely, says Alexandra Sowa, MD, an internal medicine doctor ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...

The Supreme Court on Thursday dismissed a plea seeking a direction to mandate the medical professionals to specify to ...